InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-23.9%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Explore the full record of transactions filed by Levy Howard, Directeur Médical. Insider active across 1 company, notably Catalyst Biosciences, INC.. Aggregated, 1 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €2k. Activity tracked since 9 August 2021. The latest transaction was disclosed on 9 August 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Levy Howard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
639 shares@ US$3.62100.0% of flowCommon StockSEC:0001209191-21-050758:0
Canonical exit: 7 Nov 2021 (T+90)
1 of 1 declaration
About Levy Howard
Howard Levy is the Chief Medical Officer of CATALYST BIOSCIENCES, INC. He is responsible for medical leadership and product development strategy. His expertise is essential in ensuring the quality of the company's products and services.
